NCT03237208

Brief Summary

The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 2, 2017

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2017

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2017

Completed
Last Updated

September 11, 2017

Status Verified

September 1, 2017

Enrollment Period

2 months

First QC Date

July 27, 2017

Last Update Submit

September 8, 2017

Conditions

Keywords

Transcutaneous electrical nerve stimulationemergency medicine

Outcome Measures

Primary Outcomes (1)

  • Reduction of the intensity of pain

    Subjects will complete 100 mm visual analog scales at time zero, 15 and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

    0 minutes, 15 minutes and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Secondary Outcomes (1)

  • Adverse events

    30 minutes after

Study Arms (2)

TENS

ACTIVE COMPARATOR

Patients receiving the real transcutaneous electrical nerve stimulation (TENS) with 100 hertz, pulse width 200 microseconds, voltage 2 milliampere

Device: TENS

placebo group

SHAM COMPARATOR

Patients receiving the application of transcutaneous electrical nerve stimulation, but transcutaneous electrical nerve stimulation will not be activated.

Device: placebo group

Interventions

TENSDEVICE

Transcutaneous electrical nerve stimulation (TENS) treatment will be activated.

TENS

Transcutaneous electrical nerve stimulation treatment will not be activated.

placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with renal colic admitted to emergency department.
  • Adult patients who were definitively diagnosed with acute renal colic due to urinary system stones using unenhanced computed abdominopelvic tomography

You may not qualify if:

  • Patients below 18 years of age
  • Patients with haemodynamic instability, with fever (temperature=38°C \[100.4°F\]), with evidence of peritoneal inflammation,
  • Patients using any analgesic within the previous 48 hours of emergency department presentation
  • Patients who declined to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adiyaman University Research Hospital

Adıyaman, Central, 02000, Turkey (Türkiye)

Location

Related Publications (1)

  • Simpson PM, Fouche PF, Thomas RE, Bendall JC. Transcutaneous electrical nerve stimulation for relieving acute pain in the prehospital setting: a systematic review and meta-analysis of randomized-controlled trials. Eur J Emerg Med. 2014 Feb;21(1):10-7. doi: 10.1097/MEJ.0b013e328363c9c1.

    PMID: 23839103BACKGROUND

MeSH Terms

Conditions

Renal Colic

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Umut Gulacti, M.D.

    Adiyaman University of Medical Faculty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 27, 2017

First Posted

August 2, 2017

Study Start

June 12, 2017

Primary Completion

August 12, 2017

Study Completion

August 20, 2017

Last Updated

September 11, 2017

Record last verified: 2017-09

Locations